Symposia

Can Vessel Preparation Improve Endovascular Intervention Outcomes in Arteriovenous Access? A Single Operator`s Review

02/25/2019

In this interview, Allen Lazenby, MD, shares insights into the abstract he presented at ISET 2019. Questions asked include:

Can you briefly describe your findings?

Tell us about something surprising you encountered in your review.

How might your findings eventually affect clinical practice?

What kind of future studies would you like to see take place?

What are you hoping that attendees take away from your presentation?

Stay in the Know

Vascular Disease Management Newsletter

News

Renal Denervation

First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation

07/25/2024

The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...

The study will focus on...

07/25/2024

Cath Lab Digest

Ischemic Stroke

Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke

07/24/2024

“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...

“The observed data showed all...

07/24/2024

Cath Lab Digest

News

HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025

07/22/2024

LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.

LINC, the world’s premier...

07/22/2024

Vascular Disease Management

News

Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology

07/17/2024

More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology

More than $274,000 in NSF...

07/17/2024

Vascular Disease Management

Ischemic Stroke

Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke

07/17/2024

Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.

Based on physician feedback, the...

07/17/2024

Cath Lab Digest

Peripheral Intervention

FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature

07/16/2024

“The XO technology has shown effectiveness modifying, cracking, and dilating intimal and medial calcium using low pressures,” said Richard Saxon, MD, FSIR of Tri-City Medical, San Diego, California.

“The XO technology has shown...

07/16/2024

Cath Lab Digest

News

Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter

07/09/2024

Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...

Transit Scientific Press...

07/09/2024

Vascular Disease Management

Vascular Closure

Cordis Receives FDA Approval for MYNX CONTROL VENOUS Vascular Closure Device

07/09/2024

Leveraging GRIP TECHNOLOGY™, based on hydrophilic, bioinert polyethylene glycol (PEG), the MYNX CONTROL™ VENOUS VCD sealant resorbs 3x faster than collagen-based sealants and provides the quickest time to hemostasis of any venous closure...

Leveraging GRIP TECHNOLOGY™,...

07/09/2024

Cath Lab Digest

Coronary In-stent Restenosis

CIS is First in the Capital Region to Use the AGENT™ Drug-Coated Balloon to Treat Coronary In-Stent Restenosis

07/03/2024

ZACHARY, LA – Dr. Abdullah Munir, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in the Capital Region and second in Louisiana to use the AGENT™ Drug-Coated Balloon, the first FDA-approved drug-coated...

ZACHARY, LA – Dr. Abdullah...

07/03/2024

Vascular Disease Management

thoracic endovascular aortic repair

First Commercial Implant of the GORE® TAG® Thoracic Branch Endoprosthesis in Canada

06/28/2024

The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...

The first flexible,...

06/28/2024

Vascular Disease Management

Can Vessel Preparation Improve Endovascular Intervention Outcomes in Arteriovenous Access? A Single Operator`s Review

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products